Western States Biopharmaceuticals and University of Colorado Announce Exclusive Licensing Agreement for TCISM™ Targets to Treat Autoimmune Diseases

Thursday, July 8, 2010 General News
Email Print This Page Comment
Font : A-A+

Licensed Technology is a Novel Approach to Treating Inflammatory Disease while Preserving Immune Protection

For Western States Biopharmaceuticals:

Felicia Vonella, LAS Communications

(917) 826-3427

felicia@lascommunications.com

For University of Colorado:

Lindsay Polak

Technology Transfer Office

(303) 735-5518

lindsay.polak@cu.edu



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook